CATALYST BIOSCIENCES INC's ticker is CBIO and the CUSIP is 14888D208. A total of 33 filers reported holding CATALYST BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,222 | +37.2% | 12,900 | 0.0% | 0.00% | – |
| Q2 2023 | $4,536 | -65.2% | 12,900 | -79.5% | 0.00% | – |
| Q1 2023 | $13,020 | -24.1% | 62,900 | +93.4% | 0.00% | – |
| Q4 2022 | $17,154 | -25.4% | 32,520 | -29.5% | 0.00% | – |
| Q3 2022 | $23,000 | -60.3% | 46,120 | +41.9% | 0.00% | – |
| Q2 2022 | $58,000 | +176.2% | 32,500 | 0.0% | 0.00% | – |
| Q1 2022 | $21,000 | -30.0% | 32,500 | -0.9% | 0.00% | – |
| Q4 2021 | $30,000 | -94.4% | 32,800 | -74.7% | 0.00% | – |
| Q3 2021 | $532,000 | -9.1% | 129,553 | -4.1% | 0.00% | -100.0% |
| Q2 2021 | $585,000 | -9.2% | 135,129 | +5.8% | 0.00% | 0.0% |
| Q1 2021 | $644,000 | -39.6% | 127,703 | -24.4% | 0.00% | 0.0% |
| Q4 2020 | $1,066,000 | +238.4% | 168,918 | +130.8% | 0.00% | – |
| Q3 2020 | $315,000 | -9.5% | 73,202 | +23.6% | 0.00% | – |
| Q2 2020 | $348,000 | -40.5% | 59,202 | +38.0% | 0.00% | -100.0% |
| Q4 2017 | $585,000 | – | 42,890 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 471,448 | $5,502,000 | 3.04% |
| ACUTA CAPITAL PARTNERS, LLC | 830,000 | $9,686,000 | 1.72% |
| NEXTHERA CAPITAL LP | 786,865 | $9,183,000 | 1.42% |
| Ghost Tree Capital, LLC | 355,000 | $4,143,000 | 1.22% |
| Point72 Europe (London) LLP | 83,500 | $974,000 | 0.52% |
| Virtus ETF Advisers LLC | 31,061 | $362,000 | 0.32% |
| Eventide Asset Management | 246,000 | $2,871,000 | 0.12% |
| Kalos Management, Inc. | 8,500 | $244,000 | 0.11% |
| MARSHALL WACE, LLP | 550,352 | $6,423,000 | 0.10% |
| GSA CAPITAL PARTNERS LLP | 157,145 | $1,834,000 | 0.09% |